Ranbaxy Said To Mull Cuts In Global Sales Staff, Mainly In U.S.
This article was originally published in PharmAsia News
Executive Summary
Troubled Ranbaxy Laboratories plans to reduce its global sales force of 14,600, most of them in the U.S. where its latest problems have occurred, a source said.